Floatz logo

Karxt

Bipolar Disorder Type I With Mania

Bristol-Myers SquibbunclassifiedPhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

33 Active assets in the Bipolar Disorder Type I With Mania cohort.

Asset / SponsorPhaseRating
Lurasidone
Massachusetts General Hospital
Phase 4BBB
Cipralex
Massachusetts General Hospital
Phase 4BBB
LITHIUM, ELEMENTAL
Alzamend Neuro, Inc.
Phase 4BBB
Olanzapine
Alkermes, Inc.
Phase 4BBB
Valproic Acid
Bristol-Myers Squibb
Phase 4BBB

View all 50 →

Same molecule, other indications

Karxt is also rated in:

autism spectrum disorderDormant
B
Indicative ·
60 / 100
View asset →
AgitationDormant
B
Indicative ·
60 / 100
View asset →
schizophreniaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →